UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 34

Sortiert nach

Next-generation active immunization approach for synucleinopathies: implications for Parkinson’s disease clinical trials

Acta neuropathologica, 2014-06, Vol.127 (6), p.861-879

2014

Volltextzugriff (PDF)

Active immunization against alpha-synuclein ameliorates the degenerative pathology and prevents demyelination in a model of multiple system atrophy

Molecular neurodegeneration, 2015-03, Vol.10 (1), p.10-10, Article 10

2015

Volltextzugriff (PDF)

Active immunization against complement factor C5a: a new therapeutic approach for Alzheimer's disease

Journal of neuroinflammation, 2015-08, Vol.12 (1), p.150-150, Article 150

2015

Volltextzugriff (PDF)

Distribution of Alarin Immunoreactivity in the Mouse Brain

Journal of molecular neuroscience, 2012-01, Vol.46 (1), p.18-32

2012

Volltextzugriff (PDF)

Alarin is a vasoactive peptide

Proceedings of the National Academy of Sciences - PNAS, 2007-06, Vol.104 (24), p.10217-10222

2007

Volltextzugriff (PDF)

Tailoring the antibody response to aggregated Aß using novel Alzheimer-vaccines

PloS one, 2015-01, Vol.10 (1), p.e0115237-e0115237

2015

Volltextzugriff (PDF)

Galanin Receptor Subtype GalR2 Mediates Apoptosis in SH-SY5Y Neuroblastoma Cells

Endocrinology (Philadelphia), 2004-02, Vol.145 (2), p.500-507

2004

Volltextzugriff (PDF)

Gangliocytes in neuroblastic tumors express alarin, a novel peptide derived by differential splicing of the galanin-like peptide gene

Journal of molecular neuroscience, 2006-01, Vol.29 (2), p.145-152

2006

Volltextzugriff (PDF)

Activation of chloride secretion via proteinase-activated receptor 2 in a human eccrine sweat gland cell line - NCL-SG3

Experimental dermatology, 2008-06, Vol.17 (6), p.505-511

2008

Volltextzugriff (PDF)

Pharmacological and functional characterization of galanin-like peptide fragments as potent galanin receptor agonists

Neuropeptides (Edinburgh), 2005-06, Vol.39 (3), p.179-184

2005

Volltextzugriff (PDF)

Evaluation of modified Interferon alpha mRNA constructs for the treatment of non-melanoma skin cancer

Scientific reports, 2018-08, Vol.8 (1), p.12954-10, Article 12954

2018

Volltextzugriff (PDF)

Pyroglutamylated amyloid-β is associated with hyperphosphorylated tau and severity of Alzheimer’s disease

Acta neuropathologica, 2014-07, Vol.128 (1), p.67-79

2014

Volltextzugriff (PDF)

Effects of single and combined immunotherapy approach targeting amyloid β protein and α-synuclein in a dementia with Lewy bodies–like model

Alzheimer's & dementia, 2019-09, Vol.15 (9), p.1133-1148

2019

Volltextzugriff (PDF)

Detection of peri-synaptic amyloid-β pyroglutamate aggregates in early stages of Alzheimer's disease and in AβPP transgenic mice using a novel monoclonal antibody

Journal of Alzheimer's disease, 2012-01, Vol.28 (4), p.783

2012

Volltextzugriff (PDF)

Distribution of the regulatory peptide alarin in the eye of various species

Experimental eye research, 2013-01, Vol.106, p.74-81

2013

Volltextzugriff (PDF)

Pyroglutamylated amyloid-[beta] is associated with hyperphosphorylated tau and severity of Alzheimer's disease

Acta neuropathologica, 2014-07, Vol.128 (1), p.67

2014

Volltextzugriff (PDF)

Pyroglutamate-targeting Aβ AFFITOPE® vaccines reached clinical testing : Rationale and State-of-the-Art

Alzheimer's & dementia, 2011-07, Vol.7 (4), p.S466-S466

2011

Volltextzugriff (PDF)

P2‐479: Pyroglutamate‐targeting Aβ AFFITOPE® vaccines reached clinical testing : Rationale and State‐of‐the‐Art

Alzheimer's & dementia, 2011-07, Vol.7 (4S_Part_13), p.S466-S466

2011

Volltextzugriff (PDF)

Galanin-Like Peptides Exert Potent Vasoactive Functions In Vivo

Journal of investigative dermatology, 2007-03, Vol.127 (3), p.716-721

2007

Volltextzugriff (PDF)

Pyroglutamylated beta-amyloid is associated with hyperphosphorylated tau in human post-mortem brains

Alzheimer's & dementia, 2013-07, Vol.9 (4), p.P364-P364

2013

Volltextzugriff (PDF)

P2–058: Pyroglutamylated beta‐amyloid is associated with hyperphosphorylated tau in human post‐mortem brains

Alzheimer's & dementia, 2013-07, Vol.9 (4S_Part_9), p.P364-P364

2013

Volltextzugriff (PDF)

Alarm is a vasoactive peptide

Proceedings of the National Academy of Sciences - PNAS, 2007-06, Vol.104 (24), p.10217

2007

Volltextzugriff (PDF)

Pyroglutamate modified Abeta accumulates around synapses and micro-plaques early in the development of Alzheimer's disease

Alzheimer's & dementia, 2010-07, Vol.6 (4), p.S542-S542

2010

Volltextzugriff (PDF)

P3‐309: Pyroglutamate modified Abeta accumulates around synapses and micro‐plaques early in the development of Alzheimer's disease

Alzheimer's & dementia, 2010-07, Vol.6 (4S_Part_18), p.S542-S542

2010

Volltextzugriff (PDF)

Expression of Neuropeptide Galanin and Galanin Receptors in Human Skin

Journal of investigative dermatology, 2004-04, Vol.122 (4), p.1050-1053

2004

Volltextzugriff (PDF)

1 – 25 von 34

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(33)
Mit Volltextzugriff
(33)

Publikationsform

Artikel
(34)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Next-generation active immunization approach for synucleinopathies: implications for Parkinson’s disease clinical trials

Active immunization against alpha-synuclein ameliorates the degenerative pathology and prevents demyelination in a model of multiple system atrophy

Active immunization against complement factor C5a: a new therapeutic approach for Alzheimer's disease

Distribution of Alarin Immunoreactivity in the Mouse Brain

Alarin is a vasoactive peptide

Tailoring the antibody response to aggregated Aß using novel Alzheimer-vaccines

Galanin Receptor Subtype GalR2 Mediates Apoptosis in SH-SY5Y Neuroblastoma Cells

Gangliocytes in neuroblastic tumors express alarin, a novel peptide derived by differential splicing of the galanin-like peptide gene

Activation of chloride secretion via proteinase-activated receptor 2 in a human eccrine sweat gland cell line - NCL-SG3

Pharmacological and functional characterization of galanin-like peptide fragments as potent galanin receptor agonists

Evaluation of modified Interferon alpha mRNA constructs for the treatment of non-melanoma skin cancer

Pyroglutamylated amyloid-β is associated with hyperphosphorylated tau and severity of Alzheimer’s disease

Effects of single and combined immunotherapy approach targeting amyloid β protein and α-synuclein in a dementia with Lewy bodies–like model

Detection of peri-synaptic amyloid-β pyroglutamate aggregates in early stages of Alzheimer's disease and in AβPP transgenic mice using a novel monoclonal antibody

Distribution of the regulatory peptide alarin in the eye of various species

Pyroglutamylated amyloid-[beta] is associated with hyperphosphorylated tau and severity of Alzheimer's disease

Pyroglutamate-targeting Aβ AFFITOPE® vaccines reached clinical testing : Rationale and State-of-the-Art

P2‐479: Pyroglutamate‐targeting Aβ AFFITOPE® vaccines reached clinical testing : Rationale and State‐of‐the‐Art

Galanin-Like Peptides Exert Potent Vasoactive Functions In Vivo

Pyroglutamylated beta-amyloid is associated with hyperphosphorylated tau in human post-mortem brains

P2–058: Pyroglutamylated beta‐amyloid is associated with hyperphosphorylated tau in human post‐mortem brains

Alarm is a vasoactive peptide

Pyroglutamate modified Abeta accumulates around synapses and micro-plaques early in the development of Alzheimer's disease

P3‐309: Pyroglutamate modified Abeta accumulates around synapses and micro‐plaques early in the development of Alzheimer's disease

Expression of Neuropeptide Galanin and Galanin Receptors in Human Skin

Suchergebnisse filtern